Research ExplorerPublicationsImmunosuppression and renal outcome in congenital and pediat...

Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome.

Standard

Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome. / Büscher, Anja K; Kranz, Birgitta; Büscher, Rainer; Hildebrandt, Friedhelm; Dworniczak, Bernd; Pennekamp, Petra; Kuwertz-Bröking, Eberhard; Wingen, Anne-Margret; John, Ulrike; Kemper, Markus J.; Monnens, Leo; Hoyer, Peter F; Weber, Stefanie; Konrad, Martin.

In: CLIN J AM SOC NEPHRO, Vol. 5, No. 11, 11, 2010, p. 2075-2084.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Büscher, AK, Kranz, B, Büscher, R, Hildebrandt, F, Dworniczak, B, Pennekamp, P, Kuwertz-Bröking, E, Wingen, A-M, John, U, Kemper, MJ, Monnens, L, Hoyer, PF, Weber, S & Konrad, M 2010, 'Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome.', CLIN J AM SOC NEPHRO, vol. 5, no. 11, 11, pp. 2075-2084. <http://www.ncbi.nlm.nih.gov/pubmed/20798252?dopt=Citation>

APA

Büscher, A. K., Kranz, B., Büscher, R., Hildebrandt, F., Dworniczak, B., Pennekamp, P., Kuwertz-Bröking, E., Wingen, A-M., John, U., Kemper, M. J., Monnens, L., Hoyer, P. F., Weber, S., & Konrad, M. (2010). Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome. CLIN J AM SOC NEPHRO, 5(11), 2075-2084. [11]. http://www.ncbi.nlm.nih.gov/pubmed/20798252?dopt=Citation

Vancouver

Büscher AK, Kranz B, Büscher R, Hildebrandt F, Dworniczak B, Pennekamp P et al. Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome. CLIN J AM SOC NEPHRO. 2010;5(11):2075-2084. 11.

Bibtex

@article{036feb6f72284d44b23fa1c4d9f75310,
title = "Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome.",
abstract = "Mutations in podocyte genes are associated with steroid-resistant nephrotic syndrome (SRNS), mostly affecting younger age groups. To date, it is unclear whether these patients benefit from intensified immunosuppression with cyclosporine A (CsA). The aim of this study was to evaluate the influence of podocyte gene defects in congenital nephrotic syndrome (CNS) and pediatric SRNS on the efficacy of CsA therapy and preservation of renal function. Design, settings, participants, ; measurements: Genotyping was performed in 91 CNS/SRNS patients, irrespective of age at manifestation or response to CsA.",
author = "B{\"u}scher, {Anja K} and Birgitta Kranz and Rainer B{\"u}scher and Friedhelm Hildebrandt and Bernd Dworniczak and Petra Pennekamp and Eberhard Kuwertz-Br{\"o}king and Anne-Margret Wingen and Ulrike John and Kemper, {Markus J.} and Leo Monnens and Hoyer, {Peter F} and Stefanie Weber and Martin Konrad",
year = "2010",
language = "Deutsch",
volume = "5",
pages = "2075--2084",
journal = "CLIN J AM SOC NEPHRO",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "11",

}

RIS

TY - JOUR

T1 - Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome.

AU - Büscher, Anja K

AU - Kranz, Birgitta

AU - Büscher, Rainer

AU - Hildebrandt, Friedhelm

AU - Dworniczak, Bernd

AU - Pennekamp, Petra

AU - Kuwertz-Bröking, Eberhard

AU - Wingen, Anne-Margret

AU - John, Ulrike

AU - Kemper, Markus J.

AU - Monnens, Leo

AU - Hoyer, Peter F

AU - Weber, Stefanie

AU - Konrad, Martin

PY - 2010

Y1 - 2010

N2 - Mutations in podocyte genes are associated with steroid-resistant nephrotic syndrome (SRNS), mostly affecting younger age groups. To date, it is unclear whether these patients benefit from intensified immunosuppression with cyclosporine A (CsA). The aim of this study was to evaluate the influence of podocyte gene defects in congenital nephrotic syndrome (CNS) and pediatric SRNS on the efficacy of CsA therapy and preservation of renal function. Design, settings, participants, ; measurements: Genotyping was performed in 91 CNS/SRNS patients, irrespective of age at manifestation or response to CsA.

AB - Mutations in podocyte genes are associated with steroid-resistant nephrotic syndrome (SRNS), mostly affecting younger age groups. To date, it is unclear whether these patients benefit from intensified immunosuppression with cyclosporine A (CsA). The aim of this study was to evaluate the influence of podocyte gene defects in congenital nephrotic syndrome (CNS) and pediatric SRNS on the efficacy of CsA therapy and preservation of renal function. Design, settings, participants, ; measurements: Genotyping was performed in 91 CNS/SRNS patients, irrespective of age at manifestation or response to CsA.

M3 - SCORING: Zeitschriftenaufsatz

VL - 5

SP - 2075

EP - 2084

JO - CLIN J AM SOC NEPHRO

JF - CLIN J AM SOC NEPHRO

SN - 1555-9041

IS - 11

M1 - 11

ER -